INVISTA gets patent for engineered polypeptides

Still catching up on press releases from last month…

The United States Patent and Trademark Office recently granted INVISTA a U.S. patent for engineered polypeptides and their related crystal structure details, which are both useful for producing bio-derived compounds such as butadiene and isoprene. INVISTA collaborated with Arzeda to develop the innovations covered by the patent, which was issued on Dec. 29, 2015.

“The work detailed in this patent provides innovative solutions to potentially increase the global supply of bio-derived chemicals,” said Bill Greenfield, president of INVISTA’s Intermediates business.

Alexandre Zanghellini, co-founder and chief executive officer at Arzeda, said, “The issuance of this patent is yet another example of the power of combining Arzeda’s computational protein design technology Archytas™ with experimental screening to rapidly design synthetic enzymes. With INVISTA’s expertise in biotechnology and industrial scale-up, we are confident this collaboration will lead to advanced bio-processes for the production of more sustainable industrial chemicals.”